F C Kauffman

1.7k citations
57 papers · 1.4k indexed · h-index 20

F C Kauffman

57 papers receiving 1.3k citations

Peers

F C Kauffman
Comparison fields: 5 of 102
  • Pharmacology 415
  • Hepatology 220
  • Biochemistry 158
  • Clinical Biochemistry 116
  • Neurology 156
Replace Ada Serroni with:
Ada Serroni United States
Kenichi Kitani Japan
Francesca Mirabelli Italy
Anna‐Liisa Nieminen United States
John J. Lemasters United States
Francis A.X. Schanne United States
Rosella Fulceri Italy
Claudia Zwingmann Canada
Carmen Dı́ez-Fernández Spain
Tamihide Matsunaga Japan
F C Kauffman relative to Ada Serroni United States Ada Serroni's profile →
Citations per field
00.5×4.7×
Ada Serroni · 1×
Citations per year

Countries citing papers authored by F C Kauffman

Since Specialization
Citations

This map shows the geographic impact of F C Kauffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F C Kauffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F C Kauffman more than expected).

Fields of papers citing papers by F C Kauffman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F C Kauffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F C Kauffman. The network helps show where F C Kauffman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside F C Kauffman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with F C Kauffman Line = papers co-authored together F C Kauffman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 1993232
2 199238
3 199013
4 199016
5 198917
6 19892
7 198810
8 198817
9 198828
10 198618
11 198623
12 198653
13 198631
14 198467
15 19846
16 198158
17
The pharmacology of pumiliotoxin-B. I. Interaction with calcium sites in the sarcoplasmic reticulum of skeletal muscle.
198126
18 197912
19 197634
20 197619

About F C Kauffman

F C Kauffman is a scholar working on Pharmacology, Biochemistry and Clinical Biochemistry, having authored 57 papers that have together received 1.4k indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (9 papers), Liver Disease Diagnosis and Treatment (9 papers), Drug-Induced Hepatotoxicity and Protection (9 papers), Metabolism and Genetic Disorders (7 papers), Pharmacogenetics and Drug Metabolism (7 papers), Diet and metabolism studies (5 papers), Pain Mechanisms and Treatments (5 papers) and Alcohol Consumption and Health Effects (5 papers). The work is most often cited by research in Pharmacology (415 citations), Hepatology (220 citations) and Biochemistry (158 citations). F C Kauffman has collaborated with scholars based in United States. Frequent co-authors include Ronald G. Thurman, Steven A. Belinsky, Barbara Keller, Miles J. Edwards, K. A. Conger, Julio Herrero García, A. S. Lossinsky, Mostafa Z. Badr, James G. Conway and Edson X. Albuquerque. Their work appears in journals such as Journal of Biological Chemistry, Journal of Neuroscience and Biochemical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026